←
Aptar1,795 posts
Aptar avatar

Aptar

@aptar

We innovating and transform ideas into solutions that improve everyday life

◷ Joined October 2012▧ 1,589 Photos and videos
Aptar avatar
Aptar@aptar·12h

In a recently published article, learn how #AptarPharma and Moine Recyclage are partnering to recover clean elastomer production scrap from injectable component manufacturing and repurpose it for durable technical applications. ow.ly/NEnX5107qLQ

Post attachment
Aptar avatar
Aptar@aptar·Nov 17

The #NGP #pMDI conversation has moved from “when?” to “how?”. #AptarPharma’s webinar on November 30 will explore what’s changed, what it means for pMDI development & the practical decisions teams face. Choose your session: 10:00 or 16:00 CET. Register: ow.ly/T3VP5107csP

Post attachment
Aptar avatar
Aptar@aptar·Nov 12

Aptar Pharma's Boonton, NJ, facility has received controlled substances registration, authorizing the handling, storage, manufacturing & testing of Schedule II-III controlled substances, expanding its capabilities for OINDPs. ow.ly/RKy05106iss

Post attachment
Aptar avatar
Aptar@aptar·Nov 4

Read Aptar Pharma's blog exploring 5 trends shaping the future of #nasaldrugdelivery, as the conversation evolves beyond whether a therapy can be delivered nasally to where the nasal route can create meaningful value for patients & development programs: ow.ly/lXXs5102XE2

Post attachment
Aptar avatar
Aptar@aptar·Nov 3

Registration is now open for #RDDEurope2027, April 27-30, Antibes, France, proudly co-organized by RDD Online® and #AptarPharma. Early Bird discounted registration is available until January 29, 2027 & the Poster Abstract deadline is January 15. More info: ow.ly/OJbm5102T0B

Post attachmentPost attachment
Aptar avatar
Aptar@aptar·Nov 2

What if USP <382> could provide valuable development insights before formal validation begins? #AptarPharma’s latest article explores how a system-level approach can help identify potential risk drivers earlier. Read the full article: ow.ly/RUGS5102VAb #USP382 #Injectables

Post attachment
Aptar avatar
Aptar@aptar·Oct 27

Aptar Pharma announces a collaboration with Stevanato Group, combining glass syringes & elastomer components to provide system-level data earlier in development & help inform packaging decisions for injectable therapies. ow.ly/XNLT5101gR5 #AptarPharma #Injectables

Post attachment
Aptar avatar
Aptar@aptar·Oct 26

Aptar Pharma acquires PULMOTREE, expanding growth opportunities in next-generation #pulmonary #drugdelivery. The acquisition is expected to accelerate development and commercialization of the Kolibri™ Non-Propellant Liquid Inhaler. Full Press Release: ow.ly/POfG5101b2r

Post attachment
Aptar avatar
Aptar@aptar·Oct 26

Join Aptar Pharma’s David Farrow on 2 Nov for a webinar exploring how molecular understanding, predictive science and in silico modelling can help inform formulation strategy for inhaled biologics. Register for one of two sessions: ow.ly/IqLA5100zRg

Post attachment